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This exploratory-descriptive, non-experimental quantitative research aimed to learn about immediate
adverse reactions to intravenous iodinated contrast media in hospitalized patients submitted to computed
tomography at a teaching hospital in the South of Brazil. During the study period, all adverse reactions showed
mild intensity, at a frequency of 12.5% with ionic iodinated contrast media, and 1% with non-ionic contrast
agent. The extravasation of contrast occurred in 2.2% of the injections in a peripheral vein without complications
in any of the cases. The results are within the limits cited in international literature and suggest that tomography
service professionals should know their own rates of adverse reactions to iodinated contrast agent, as well as
the conditions in which they occur, in order to obtain evidence to evaluate the respective care delivery processes.
DESCRIPTORS: contrast media/adverse effects; extravasation of diagnostic and therapeutic materials/nursing;
tomography spiral computed; drug monitoring
REACCIONES ADVERSAS INMEDIATAS AL CONTRASTE YODADO
INTRAVENOSO EN TOMOGRAFÍA COMPUTARIZADA
Investigación cuantitativa del tipo exploratorio-descriptivo, de carácter no experimental. El objetivo
consistía en conocer las reacciones adversas inmediatas al contraste yodado intravenoso en pacientes internados,
sometidos a tomografía computarizada en un hospital escuela del sur de Brasil. Durante el período del estudio,
todas las reacciones adversas tuvieron intensidad leve y una frecuencia del 12,5% con la utilización del contraste
yodado iónico, y 1% con contraste no iónico. La extravasación del contraste ocurrió en un 2,2% de las inyecciones
en vena periférica, no ocasionando complicaciones en ninguno de los casos. Los índices evidenciados en el
presente estudio se mantuvieron dentro de los límites que constan en la revisión de literatura y, entre las
recomendaciones, se sugiere que los servicios de tomografía conozcan los propios índices de reacciones
adversas al contraste yodado y las condiciones en que ocurren, con la finalidad de obtener evidencias para
evaluación de los respectivos procesos asistenciales.
DESCRIPTORES: medios de contraste/efectos adversos; extravasación de materiales terapéuticos y diagnósticos/
enfermería; tomografía computarizada espiral; monitoreo de drogas
REAÇÕES ADVERSAS IMEDIATAS AO CONTRASTE IODADO
INTRAVENOSO EM TOMOGRAFIA COMPUTADORIZADA
Pesquisa quantitativa, exploratório-descritiva, de caráter não experimental, com o objetivo de conhecer
as reações adversas imediatas ao contraste iodado intravenoso em pacientes hospitalizados, submetidos a
tomografia computadorizada num hospital-escola no Sul do Brasil. Durante o período de estudo, todas as
reações adversas manifestaram-se na intensidade leve, com freqüência de 12,5% com o uso de contraste
iodado iônico e 1% com contraste não iônico. Extravasamento do meio radiopaco ocorreu em 2,2% das
injeções em veia periférica, não havendo complicações em nenhum dos casos. Os resultados encontram-se
dentro dos limites citados na literatura internacional e sugere-se que os serviços de tomografia conheçam as
próprias taxas de reações adversas ao contraste iodado e as condições em que elas ocorrem, a fim de obter
evidências para a avaliação dos respectivos processos assistenciais.
DESCRITORES: meios de contraste/efeitos adversos; extravasamento de materiais terapêuticos e diagnósticos;
enfermagem; tomografia computadorizada espiral; monitoramento de medicamentos
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INTRODUCTION
Adverse reactions to iodinated contrast
medium happen relatively frequently in daily work at
imaging units, and their occurrence can range from
light forms to life-threatening events. International
studies indicate that these events occur in between
0.2 and 12.7% of contrast injections, depending on
the type and characteristics of the radiopaque
substance that is used(1-2). However, there are no
national publications about the frequency of these
reactions in Brazilian radiology services. Thus, this
research aimed to find out about immediate adverse
reactions presented by hospitalized patients submitted
to computed tomography (CT) with intravenous
iodinated contrast, at a teaching hospital in the South
of Brazil. A further goal was to identify the frequency
of these events and establish a parallel with results
from international references. This knowledge can
support care and management decisions, contributing
to more qualified and specialized care delivery to
clients submitted to tomographies.
LITERATURE REVIEW
Iodinated contrast is a radiopaque substance
used in radiology exams like computed tomography,
which is widely used for diagnostic purposes. Although
it improves the visualization of anatomic structures
during the exam, this substance can provoke
unwanted adverse effects, mainly due to the contrast’s
high osmolality in relation to blood(3). Ionic iodinated
contrast is dissociated in ions when solved and its
osmolality is higher than that of so-called non-ionic
compounds, which do not dissociate into electrically-
loaded particles. Therefore, the non-ionic medium is
safer and has a better tolerability, but its high cost
impedes its indiscriminate use(4-5).
Adverse reactions (AR) or unwanted effects
resulting from iodinated contrast administration are
generally classified, in terms of etiology, in
anaphylactoid and chemotoxic reactions.
Anaphylactoid or idiosyncratic reactions do not depend
on the administered contrast dose and are similar to
allergic reactions, taking the form of urticaria, nasal
cold, hypotension accompanied by tachycardia,
bronchial spasm and laryngeal edema, as well as
more intense manifestations like shock and severe
respiratory failure. Chemotoxic or non-idiosyncratic
reactions are dose-dependent and related to the
contrast’s physical-chemical characteristics, such as
osmolality and ionicity. Their signs and symptoms can
include feelings of heat, nausea and vomiting, heart
arrhythmia, hypertension, renal failure and
convulsions, among others(4). As to severity level,
reactions are classified as light, when they pass
spontaneously and no therapy is needed; moderate,
when the reaction recedes through medication
intervention, without needing hospitalization; and
severe, when life-support measures and
hospitalization are required(2,4). Adverse reactions are
called acute when they occur within 30 minutes after
contrast administration and late when they occur after
30 minutes and up to seven days later(5). Risk factors
associated with the occurrence of adverse reactions
to iodinated contrast include previous history of
adverse reactions to radiopaque medium, history of
asthma or allergies, heart arrhythmias, ischemic heart
disease, general weakness, impaired communication,
anxiety, kidney failure, extreme age and concomitant
use of some drugs, such as beta blockers, metformin
and nephrotoxic agents(4-6). The frequency of adverse
events associated with iodinated contrast ranges
between 2.2 and 12.7% when ionic medium is used
and between 0.2 and 3.1% when non-ionic contrast
is used(1-2,7).
Iodinated contrast extravasation is
considered a local adverse effect of intravenous
radiopaque substance administration. Most
extravasations involve small volumes of less than 10
ml, evolving without complications; however, large
volumes of 50 ml or more can damage neighboring
tissues of the puncture site and, rarely, compartmental
syndrome(6). According to international literature(2,8-
10), the frequency of radiopaque medium extravasation
varies between 0.3% and 3.6%. Some risk factors
for the occurrence of contrast extravasation are
fragility of the venous network, venipunctures with
metallic needles in comparison with plastic catheters,
previously catheterized veins, multiple puncture
attempts, impaired communication, extreme age,
earlier or current chemotherapy or radiotherapy
treatment(6,11).
The nursing team active in computed
tomography services plays an important role in the
prevention, detection and treatment of adverse effects
caused by iodinated contrast use. At the research
hospital, nursing examines the presence of risk
factors for the occurrence of these reactions, provides
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for venous access and injects the contrast agent.
Moreover, nursing professionals identify signs of
systemic or local adverse reactions and implement
the treatment needed for each case. Hence, the
monitoring of adverse events deriving from
tomographies is a tool to assess care delivery at this
service and an important care quality indicator.
METHOD
A quantitative, exploratory-descriptive and
prospective study was carried out at the Radiology
Service of the Porto Alegre Hospital de Clínicas (HCPA).
This general public hospital belongs to the hospital
network of the Brazilian Health Ministry and is
academically affiliated with Rio Grande do Sul Federal
University (UFRGS). The HCPA has approximately 830
beds and, every month, the Tomography Unit performs
about 900 tomographic exams. This non-experimental
research was favorably assessed by the Research
Group and the Graduate Program at the institution
through amendment 1 of Project GPPG 02-342. Data
were collected through a registry framework, filled out
manually by the nursing team during the service’s
functioning hours (24/24), including all hospital patients
who underwent contrasted CT between October 1st and
December 10th 2004. After the exam, patients were
assessed for the occurrence of immediate adverse
reactions deriving from the use of intravenous iodinated
contrast during the 30 minutes after the radiopaque
medium was administered. At the end of the data
collection period, a sample of 351 subjects was
obtained, 161 of whom received ionic iodinated contrast
(meglumine diatrizoate) and 190 received non-ionic
iodinated contrast (ioversol). To study extravasation,
only subjects who received the contract injection
through peripheral venous access were included,
totaling 317 patients.
Data were treated through descriptive and
analytic statistics, using SPSS v. 12.0, EPI INFO v. 6
and PEPI v. 3. Chi-square and Fisher’s exact test were
used to check for possible associations between
variables, considering p<0.05 as significant, with a
95% confidence interval (CI).
Next, in the results section, findings related
to extravasation of the radiopaque medium were
described separately, as this is a local adverse effect
for which different sample subject inclusion and
exclusion criteria were adopted.
IMMEDIATE ADVERSE REACTIONS
In the group of 160 patients who received
ionic iodinated contrast, we found 20 cases of
immediate adverse reactions, corresponding to a
frequency of 12.5% (CI95%:8.0%;18.3%). Eighty-five
percent of reactions were anaphylactoid, mainly
characterized by pruritic papules and, less frequently,
by face hyperemia and sneezing. Chemotoxic
reactions only took the form of vomiting.
Among the 191 patients who received the
non-ionic medium, only two cases presented an
immediate adverse reactions, exclusively
characterized by vomiting, corresponding to a reaction
frequency of 1.0% (CI95%:0.2%;3.4%). This rate was
significantly lower than when ionic contrast agent is
used (p=0.000), supporting the assertion that the non-
ionic medium, with lower osmolality, drastically reduces
the risk of adverse reactions(4). Intensity of all events
was light, with signs and symptoms receding
spontaneously, and 54.6% of events started within
the first ten minutes after contrast administration.
In Table 1, rates found in this study are
compared with international references, showing no
significant difference between these results and a
Japanese research(1). That study included feeling hot as
an adverse reaction, with a frequency of 2.29% for ionic
medium and 0.92% for non-ionic medium, while that
symptoms was not considered here. Other authors(7)
ignore not only feeling hot, but also the occurrence of
vomiting. Therefore, when drawing a parallel with the
results of that reference source, manifestations of
vomiting were excluded. Result differences were
significant for ionic iodinated contrast usage only;
however, it should be highlighted that those researchers
do not distinguish between light and moderate reactions,
grouping them in one single category of adverse
reactions. This means that, although this study found a
higher rate of adverse events when ionic contrast was
used, these events were less severe, as they only
referred to light reactions.
Table 1 - Comparison between AR rates found in
international publications and in this study
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As to the contrast volume used for each
exam, it was observed that the radiopaque substance
dose, expressed in ml/kg, is not a determinant factor
for the occurrence of adverse reactions in general,
neither for ionic nor for non-ionic iodinated contrast.
Some studies(1-2,8) have addressed the
influence of the injection technique or contrast
administration speed on the occurrence of adverse
events, but these international research results are
controversial. In this study, we found that automatic
contrast injection significantly increased the
occurrence of adverse reactions, but only in the ionic
group: manual injection provoked AR in 3.6% of cases,
while injections through an injection bomb resulted in
17.1% (p=0.013).
When considering the influence of some client-
related variables, literature(1) reports higher
prevalence rates for all adverse reactions with both
contrast types in the age range from 20 to 29 years,
with a significant decrease in frequencies for each
year added to the patient’s age. Hence, the younger
the patient, the higher the probability of developing
an immediate or late adverse reaction to iodinated
contrast(12). In fact, in this study, the frequency of
reactions to the ionic medium decreased from the
age of 30 onwards. However, no statistically significant
difference occurred for adverse reactions in general
in different age ranges (p=0.684).
Another important characteristic of clients in
this study is that 76.6% of the sample subjects
presented one or more risk factors for developing
adverse reactions to the radiopaque substance, which
were more frequent in people over 70 (25.6%), with
a heart disease (16.0%), diabetes mellitus (11.1%)
and various allergies (10.0%). Different studies(1,12)
indicate that the rate of adverse reactions increases
about three to five times in the presence of factors
like a history of previous reaction to iodinated contrast,
various allergies and asthma. In this research, no
significant difference was found in anaphylactoid
adverse event rates with ionic iodinated contrast usage
between the group with and the groups without
allergic antecedents: 15.4% versus 10.2%,
respectively, with p=0.911.
RADIOPAQUE MEDIUM EXTRAVASATION
Contrast extravasation occurred in 7 of the 317
patients who received the injection through peripheral
venous access, corresponding to a frequency rate of
2.2% (CI95%:1.0%;4.1%), without any relation with the
type of contrast that was used. The volume of
extravasated contrast ranged between 1 and 10 ml in
85.7% of cases, and only one case (14.3%) with a volume
of 15 ml. All cases evolved favorably, without any
complication deriving from these events.
One factor that was clearly associated with
the occurrence of extravasation was the material used
for the peripheral venipuncture. Usually, venous
access is arranged immediately before the exam,
using a 21-caliber metallic needle for manual injection
and a 22-caliber plastic catheter for cases in which
the radiopaque medium will be injected automatically
through an injection bomb. Previously installed
catheters are only used if they are in good conditions,
that is, if established less than 24 to 48 hours ago,
offering a good flow of 0.9% saline solution, injected
in bolus to test the access; an adequate blood reflow;
and no sign of phlebitis, such as pain, edema or local
hyperemia. In order to avoid possible verification
biases, extravasation frequency according to the type
of venous access was calculated with a constant
manual contrast injection technique, carried out by
means of a metallic needle or plastic catheter.
Extravasation rates corresponded to 10.0% in the
group with metallic access, against 1.2% in the group
with plastic access, indicating a significant difference
in extravasation rates between the two types of
intravenous devices (p=0.041).
It is equally important to compare extravasation
rates according to the radiopaque substance injection
technique as, in recent years, the use of the injection
bomb has been related with increased occurrence levels
of this adverse event in international literature. This
relation is based on the fact that automatic injections
administer the contrast in constant and stronger flows
than manual injections(8-9).
In order to analyze extravasation frequency
according to the injection technique, the type of plastic
venous access was maintained constant, showing
extravasation in 1.2% of manual injection cases, against
1.00% when using an injection bomb. Thus, there was
no statistically important difference between both
techniques (p=1.000). However, it is emphasized that
patients who received the automatic injection were
previously assessed by the nursing team and that their
venous network was considered suitable to receive the
contrast agent through an injection bomb, while patients
with higher risk of extravasation received a manual
contrast agent injection. This may have provoked a
deviation of risk cases to the manual injection group.
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No significant differences in extravasation
rates were found between genders and age ranges.
Venous network fragility was present in 100 of the
317 sample patients, five of whom presented
extravasation. This corresponds to a 5.0%
extravasation rate among patients in this condition.
However, the difference with the group without any
risk factor was not statistically significant (p=0.101).
Literature(2, 8-10) about the occurrence of
extravasation refers to research that used some
criteria different from those used in this study, such
as the exclusive use of plastic catheters, exclusive
use of automatic injection and different criteria to
select the research subjects. In comparing the results
of this study with international references, attempts
were made to adapt results from the HCPA to the
criteria used by different researchers, as shown in
Table 2.
Only one international study(8) presented a
significantly lower percentage than results obtained
at the HCPA, although extravasated contrast volumes
ranged from 3 to 144 ml, with a mean volume of 41
ml. Thus, although higher rates were found in this
research, extravasated volumes were significantly
lower. This was fundamental for the non-occurrence
of drastic consequences in the exposed patients.
Moreover, other sources also mention higher
extravasated volumes, ranging between 3 and 120
ml(9), or do not specify the extravasated volumes(2).
The reduced extravasated volumes in this study,
corresponding to less than 10 ml, is attributed to the
fact that a nursing professional stayed at the patient’s
side during the injection, identifying signs of
extravasation at an early stage and interrupting the
contrast flow in time to prevent more severe
complications in patients exposed to this event.
Table 2 - Comparison between extravasation rates
found in international publications and in this study
Another study(10) mentioned in table 2 tested
the efficacy of an automatic accessory device linked
with the contrast injection site, which detects local
extravasation, automatically interrupts the injection
of the radiopaque medium and does not require the
health professional’s presence at the patient’s side
during the injection. This research, carried out in
Philadelphia, USA, presented the highest extravasation
rate found in literature, with extravasated volumes
ranging between 13 and 18 ml. Moreover, during the
study, false-positive cases occurred in 2.4% of
injections, which probably provoked the unnecessary
interruption of the exam.
FINAL CONSIDERATIONS
When associating these research results with
available international references, some divergences
appeared in terms of criteria used to study adverse
reactions to iodinated contrast, such as the selection
of sample subjects and the signs and symptoms
considered by the researcher.
As to the study subjects, the fact that this
sample exclusively consists of hospitalized patients
suggests a higher rate of adverse events than in studies
including outpatients. Some conditions that are very
common among hospitalized patients have already
been associated with a two- to fourfold increase in
chances for the occurrence of adverse reactions to
radiopaque medium, such as exposure to surgeries,
invasive procedures or regular medication intake during
the five days before the exam(12). With respect to
immediate adverse reactions, this research considered
vomiting, while international studies(1,7) exclude
vomiting and include other symptoms, such as feeling
hot and pain in the injection site. In other words, study
results can only be compared when samples in
equivalent health conditions are used and when the
same research subject inclusion and exclusion criteria
are adopted. However, due to the lack of information
produced in conditions similar to this study context,
references were used to provide parameters that could
indicate the adequacy or inadequacy of local results.
In this study, immediate adverse reactions to
iodinated contrast occurred at a frequency of 12.5%
among patients who received ionic medium and 1.0%
among patients exposed to non-ionic contrast. Intensity
levels of these events were light and they were solved
spontaneously. These results are within the limits
quoted in literature(1,4,7), reflecting fully acceptable and
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safe rates according to international references.
Consequently, it is considered that the strategy of
selectively using non-ionic contrast, adopted at the
service where this research was carried out, offers
adequate security standards to clients, respecting the
institution’s economic-financial restrictions and
reflecting an adequate screening of risk cases. This
demonstrates that nursing professionals have
satisfactorily contributed to these results, to the extent
that they actively participate in this decision process.
What contrast extravasation is concerned, this
occurred in 2.2% of radiopaque substance injections
through peripheral venous access, also according to
parameters found in literature(2,8-10). In a large
majority of cases, extravasated volumes remained
under 10 ml, without any complication deriving from
contrast administration in the extravascular space.
As to the material used to establish venous access,
the use of plastic catheters revealed to be significantly
safer than the use of metallic needles. International
literature already mentions this significant difference
in extravasation risks when using both materials, and
no other research was found that used metallic
needles. Thus, the use of metallic needles should be
reassessed, in view of the universal use of plastic
access, and new studies should be carried out to test
different materials, considering the cost-benefit
relation of using alternative devices.
These recommendations, based on local
research data, as well as the assessment of the
respective interventions, evidence the presence of
improvement cycles and quality management in the
health work area. Quality management has become
fundamentally important in health service management,
to the extent that it emphasizes continuous improvement
through scientific methods and data monitoring to
support decision making, with a view to achieving
maximum client satisfaction and minimizing risks that
can jeopardize the intended quality and security(13-14).
Therefore, tomography services should get to know the
occurrence rates of adverse events to radiopaque
medium and the conditions in which they occur, so as to
obtain evidence to assess the respective care processes.
The fact that the intensity of adverse events
was light and that they evolved well does not exclude
the need to maintain the work team always prepared
for emergency care. Severe events cannot be previewed
and can occur even when non-ionic contrast agent is
used, including in low risk patients, and alternative image
studies that provide the same or better diagnostic
information should be considered before administering
iodinated contrast.
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